As of November 2024, InMed Pharmaceuticals has a market cap of $680.67K. This makes InMed Pharmaceuticals the world's 36173th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $853.29K | -16.23% |
2023 | $1.02M | -79.41% |
2022 | $4.95M | -93.83% |
2021 | $80.19M | -60.18% |
2020 | $201.39M | -44.61% |
2019 | $363.60M | -29.40% |
2018 | $514.97M | -76.05% |
2017 | $2.15B | 526.24% |
2016 | $343.40M | 47.83% |
2015 | $232.30M | -4.17% |
2014 | $242.40M | 344.44% |
2013 | $54.54M | -50.91% |
2012 | $111.10M | -49.31% |
2011 | $219.17M | -35.95% |
2010 | $342.18M | 2158.48% |
2009 | $15.15M | -87.50% |
2008 | $121.20M | -96.73% |
2007 | $3.71B | -34.32% |
2006 | $5.65B | 133.13% |
2005 | $2.42B | -83.39% |
2004 | $14.60B | 175.26% |
2003 | $5.30B | 250.00% |
2002 | $1.51B | -66.67% |
2001 | $4.54B | - |